MYC and cancer: This analysis showed that tumors in the DLRS-low group were significantly enriched for multiple cancer hallmark-related pathways such as MYC signaling, KRAS signaling, and epithelial mesenchymal transition that are associated with aggressive tumor phenotypes (Figure 7A).